tenk.fyi

Dyne Therapeutics, Inc.

DYNNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$446.2M

40.6% YoY

EPS

$-3.47

3.0% YoY

Cash

$893.4M

105.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro